biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by Sinbobon Jan 15, 2012 6:07pm

186 Views

Post# 19405872

RE: RE: RE: RE: Just a thought...Technicalbuy..

Thanks very much pmrider...excellent post and info. You guys really do your homework and understand this medical technology. The effort and time spent to respond has been most intelligent, sincere and knowledgeable.

Please folks, I am not negative on this stock.

Actually, wish I had about $100,000 to throw at this...but will have to settle for something less.

Should be an interesting week....month and year here.

Bullboard Posts

Understanding tax loss season and the “Santa Claus rally”